NMS Capital Announces Partnership and Investment in Central Ohio Urology Group

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181211005258/en/

Established in 2004, COUG provides a full suite of urological services and comprehensive individualized treatment for its patients, including men’s health, women’s health and cancer care. Through its network of 18 locations in central Ohio, including a single-specialty ambulatory surgery center (“ASC”), COUG’s board-certified urologists complete more than 250,000 procedures annually. In addition to its core urology and cancer care services, COUG provides ancillary services including pharmacy, radiology, pathology, imaging and diagnostics. To support its physician and other providers, COUG operates a centralized support services office with more than 50 professionals who provide end-to-end services, including finance and accounting, revenue cycle management, provider recruitment, human-resources, compliance, data analytics and contracting.

Dr. Rush Patel and Dr. William Bloch, COUG physician shareholders and appointed board members, stated, “With extensive experience across several physician practice specialties and its commitment to a partnership approach, NMS will be instrumental in helping COUG during its next phase of growth. Partnering with NMS presents an opportunity for COUG and its employees to build upon the strong foundation already in place and ultimately allow us to accelerate growth both organically and through acquisitions. As result of the partnership, COUG will be able to expand the resources available to our patients and network of physician partners.”

Mark Cherney, COUG CEO, commented, “This investment will help build upon COUG’s position as a leader in the urology industry by supporting our continued vision and growth along with our expansion into new markets. The NMS team has a long history of accelerating growth while maintaining the company’s core values and culture. During the process of making this investment the professionals at NMS have demonstrated the values, resources and expertise to build through a partnership model. We look forward to building our platform into a world-class urology services model for other groups to seek out as a partner.”

Luis Gonzalez, Partner at NMS, remarked, “COUG represents NMS’ fifth investment in the physician practice space. The urology specialty creates a compelling opportunity to leverage our experience and track record in the provider arena. We look forward to assisting with COUG’s future patient-centered growth through acquisitions, practice and ASC openings, provider recruitment and investment in infrastructure.”

McDermott Will & Emery provided legal advice to NMS. Cain Brothers, a division of KeyBanc Capital Markets, served as exclusive financial advisor to COUG, and Squire Patton Boggs served as legal advisor to COUG.

About Central Ohio Urology Group

Central Ohio Urology Group is a leading provider of urological services with a network of more than 18 locations throughout Ohio. Headquartered just outside of Columbus in Gahanna, Ohio, COUG provides a comprehensive suite of urological services, including general urology, advanced treatment options for bladder and prostate cancer, and radiation oncology.

For additional information about COUG, visit the company’s website at www.centralohiourology.com.

About NMS Capital

NMS Capital is a New York headquartered private investment firm specializing in strategic equity investments and leveraged buyouts of lower middle market companies. The firm was formed through the spin-out of a group of portfolio companies from the Goldman Sachs Merchant Banking Division. NMS focuses on companies headquartered in the U.S. poised to benefit from sustainable growth trends with particular concentration on companies in Healthcare Services and Specialized Business Services.

For additional information about NMS, visit the firm’s website at www.nms-capital.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20181211005258/en/